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Introduction
Familial hypocalciuric hypercalcemia ( FHH] also termed familial benign hypercalcemia) is generally an asymptomatic disorder characterized by modest elevation of serum calcium concentration, relative hypocalciuria, and inappropriately normal parathyroid hormone levels. The condition is inherited as an autosomal dominant trait and the phenotype can be diagnosed soon after birth. While the penetrance of FHH approaches 100%, affected individuals exhibit virtually none of the morbidity generally associated with hypercalcemia ( 1, 2). Physiologic and biochemical studies on individuals with FHH demonstrate abnormal responses of both the kidney and the parathyroid gland to calcium (2, 3) . Although the precise genetic defect is unknown, linkage analyses have demonstrated that the disease locus in most FHH families is located on the long arm ofchromosome 3 (4, 5) . In one family, an FHH locus maps to chromosome 1 9p32 (5) .
Neonatal severe hyperparathyroidism ([NSHPT] also termed neonatal familial primary hyperparathyroidism) is a rare disease characterized by marked hypercalcemia (often > 20 mg/dl), skeletal demineralization, parathyroid hyperplasia, respiratory distress, and hypotonia (6, 7) . While severe parathyroid hyperplasia appears to be central to this metabolic disturbance, its cause is unknown. Without parathyroidectomy, NSHPT is generally fatal, though rare cases of less severely affected neonates have been successfully managed medically (8, 9) .
Since the initial report ofNSHPT in 1947 (10) and FHH in 1972 ( 1 ), physicians have frequently recognized familial coincidence of these two disorders (6, (12) (13) (14) (15) (2) . Previous studies in four families (A, B, C, D) had showed linkage ofFHH to chromosome 3q (4). Three additional FHH families (J, N, and P) and four families (described below) with both FHH and NSHPT were studied to further examine the possibility of genetic heterogeneity. Clinical evaluations of families J, N, and P were previously reported (13, 14, 16) .
Four FHH families (E, I, Q, S; Fig. 1 Genetic studies. DNA was extracted from peripheral lymphocytes or EBV-transformed lymphoblastoid cell lines as described previously (19, 20) . Genotypes of family members were defined with polymorphic markers for loci D3S1 303, D3S 1267, and D3S 1269 on chromosome 3q2 using methods described previously (4) . In all families, twopoint analyses were performed using the MLINK program as described (4, 21) (22, 23) have identified 10 polymorphic loci within 20 cM of this FHH locus. The genotypes of all members of families A, B, C, and D were defined at these 10 loci (data not shown). By assessing recombination events between FHH and each locus, the FHH gene was located in the region between loci D331303 and D3S1267 (Fig. 2) .
Three loci D3S1303, D3S 1267, and D3S 1269 were then used to assess genetic heterogeneity of FHH in seven additional families. Six families (J, N, P, E, I, S), three of whom also had NSHPT, provided sufficient information to conclude that FHH was linked to this locus (Table II) . The combined maximum lod score in these 10 families is 35.64 (0 = 0.01 from D3S 1303). While the maximum lod score in family Q favored linkage, this family was too small to independently prove linkage of FHH at this locus (maximum lod score = 0.86; Table  II ). In the four families with both FHH and NSHPT, the combined likelihood that FHH is linked to chromosome 3q21-24 is > 4,000,000:1 (lod score = 6.66; Table II) .
Genetic analyses ofNSHPT. The inheritance of NSHPT at the same three loci (D3S 1303, D3S 1267, and D3S 1269) in families E, I, Q, and S was also studied. Lod scores were calculated to compare the likelihood of the autosomal recessive inheritance ofNSHPT linked to the FHH locus hypothesis versus the likelihood of random association between the NSHPT and FHH loci in these families. These calculations depend on the haplotype frequency in the relevant ethnic group for each family. Because this information is unavailable, lod scores were calculated assuming a low haplotype frequency, a high haplotype frequency and a haplotype frequency estimated from our study population (Methods) .
Ifthe haplotype coinherited with NSHPT in the families E, I, Q, and S is very rare (frequency = 0.001), then the ratio of the likelihood that NSHPT and the FHH locus are genetically linked to the likelihood that both were inherited by chance is > 3,000,000:1 (lod score = 6.53). By contrast, ifthe frequency of each of these haplotypes is 10%, then the likelihood of linkage between NSHPT and FHH is 5,500:1 (lod score = 3.74). Using a haplotype frequency estimated from our study population the likelihood of linkage between NSHPT and FHH is > 350,000:1 (lod score = 5.56, Table II ). The haplotypes found in NSHPT patients in families E, I, Q, and S are unique, suggesting that the disease-causing mutation(s) either arose independently in each family or that any common ancestor to these families is very remote. Two identical haplotypes were present in each individual with NSHPT, demonstrating homozygosity of this locus (Fig. 1 Figure 1 . Pedigrees of four NSHPT families. Individuals are represented by squares (male), circles (female), and slashes (deceased), and they are identified by generation and pedigree numbers. Consanguinous marriages are shown as double lines. Clinical status is indicated by open symbols (unaffected), half-filled symbols (FHH), filled symbols (NSHPT), and speckled symbols (unknown), and described in Table I and Methods.
The genotypes (defined by loci D3Sl 303, D3S 1267, and D3S1269, Fig. 2 * Values measured before parathyroidectomy (E-IV-1, Q-IV-1, and I-IV-5), death (I-IV-1), or at 11 mo of age (S-VII-3). iPTH, intact parathyroid hormone; normal = 10-65 pg/ml. $ Carboxyl terminal PTH levels (ng/ml); normal < 40 ng/ml. § Died shortly after birth.
We speculate that NSHPT individuals in FHH families without consanguinity may be double heterozygotes, having inherited different mutated alleles of the FHH gene on chromosome 3q from each parent. While we can not exclude the possibility that some individuals with NSHPT may be heterozy- Recent studies (24) have suggested that heterozygous individuals with FHH exhibit a mild increase in the set point of their parathyroid glands for calcium (the Ca"+ concentration producing half of the maximal inhibition of parathyroid hormone release). In two cases (25, 26) in which the parathyroid tissue from individuals with NSHPT was studied in vitro, there was a much more marked increase in the set point for Ca"+.
We speculate that one abnormal allele of the FHH gene produces mildly abnormal Ca"+-regulated parathyroid hormone secretion, while parathyroid glands expressing two mutant alleles are only responsive to severely hypercalcemic levels of Ca". These results are consistent with the FHH gene playing an important role in the sensing of extracellular Ca"+ by the parathyroid gland.
